http://www.nature.com/mt/journal/v19/n10/abs/mt2011132a.html 1 }5 U7 I7 h6 g4 HA Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma: f' v( C( Q! G9 g* @6 C& E* x